Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 877399-60-5 Chemical Structure| 877399-60-5

Structure of 877399-60-5

Chemical Structure| 877399-60-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 877399-60-5 ]

CAS No. :877399-60-5
Formula : C8H12BrN3
M.W : 230.11
SMILES Code : BrC1=CN(C2CCNCC2)N=C1
MDL No. :MFCD15474940

Safety of [ 877399-60-5 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H318-H317-H301
Precautionary Statements:P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P264-P270-P301+P310-P321-P330-P405-P501-P280-P305+P351+P338-P310
Class:6.1
UN#:2811
Packing Group:

Application In Synthesis of [ 877399-60-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 877399-60-5 ]

[ 877399-60-5 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 877399-50-3 ]
  • [ 877399-60-5 ]
YieldReaction ConditionsOperation in experiment
A 4 M solution of HCI in 1 ,4-dioxane (13.5 ml, 54 mmol) is added to a solution of 4-(4- Bromo-pyrazol-1-yl)-piperidine -1-carboxylic acid tert-butyl ester (as obtained in preparation 62, 5.92 g , 17.94 mmol) in CH2CI2 (50 ml) and the reaction mixture is stirred at RT for 6h. The suspension is filtered on a Por. 4 Fritte and the cake dissolved in EtOAc. A saturated solution of NaHCO3 is added and the phases are separated. The aqueous phase is extracted 3chi with EtOAc. The combined organic layers are washed with NaHCO3, brine, dried over Na2SO4, filtered and the filtrate is concentrated in vacuo. The residue is used without further purification in the next step, and afford the title compound as pale orange solid, Rt = 0.582 min (Acquity UPLC BEH C18, 2.1x50mm, 1.7 micron, detection 215nM, 0.1 min 2percent CH3CN in H2O , 2percent to 100percent CH3CN in H2O in 1.5min, 0.4 min 100percent CH3CN + 0.1percent TFA, flow rate 1.0ml/min); MS: 330 (M+1 , 79Br)+
With trifluoroacetic acid; In dichloromethane; at 20℃; To a solution of <strong>[877399-50-3]4-(4-bromo-pyrazol-1-yl)-piperidine-1-carboxylic acid tert-butyl ester</strong> (500 mg, 1.515 mmol) in CH2Cl2 (3 mL) was added TFA (3 mL). The reaction was stirred at room temperature until LCMS indicated completion of the reaction. The solvents were removed in vacuo, and the residue was dissolved in MeOH (15 mL). The pH of the solution was adjusted to 9 with hydroxide resin to afford 4-(4-bromo-pyrazol-1-yl)-piperidine.
With trifluoroacetic acid; In dichloromethane; at 20℃; To a solution of <strong>[877399-50-3]4-(4-bromo-pyrazol-1-yl)-piperidine-1-carboxylic acid tert-butyl ester</strong> (500 mg, 1.515 mmol) in CH2CI2 (3 mL) was added TFA (3 mL). The reaction was stirred at room temperature until LCMS indicated completion of the reaction. The solvents were removed in vacuo, and the residue was dissolved in MeOH (15 mL). The pH of the solution was adjusted to 9 with hydroxide resin to afford 4-(4-bromo-pyrazol-1 -yl)-piperidine.
To a stirred solution of 4-(4-Bromo-pyrazol-1-yl)-pipehdine-1-carboxylic acid tert-butyl ester (1.2 g, 3.6 mmol) in CH2CI2 (4 ml) was added TFA (2 ml) and the reaction m ixture stirred at room temperature for 2 h. The volatiles were removed in vacuo and the residue partitioned between CH2CI2/NaHCO3(aq). The aqueous layer was extracted with CH2CI2 (x3), and the organic fractions combined, dried (using a phase separating cartridge) and the solvent removed in vacuo to give a solid. (0.49 g). 1 H NMR (400 MHz, CDCI3): 7.48 (1 H, s), 7.46 (1 H, s), 4.29-4.15 (1 H, m), 3.27 (2H, d), 2.99-2.75 (2H, m), 2.16 (2H, d), 2.05-1.81 (2H, m).

 

Historical Records

Technical Information

Categories